慢加急性肝衰竭患者肝移植后医疗资源利用更高
该多中心回顾性研究纳入2018至2019年北美10个中心318例肝移植患者,按EASL-CLIF标准评估慢加急性肝衰竭(ACLF)。移植时无ACLF 106例(33.3%)、ACLF-1 61例(19.1%)、ACLF-2 74例(23.2%)、ACLF-3 77例(24.2%)。ACLF患者移植后住院时长、透析时长、出院至康复中心比例及30天再入院率均高于无ACLF患者。
要点
- 移植时ACLF-3者术后住院时长较无ACLF者延长19.3天(95%CI 1.2-39.7)。
- 移植时ACLF-3者术后透析时长较无ACLF者延长9.7天(95%CI 4.6-48.8)。
- 移植时ACLF-1、ACLF-2、ACLF-3者出院至康复中心的OR分别为1.79、2.23、2.23。
核心结论
- 移植时存在ACLF、尤其是ACLF-3的患者,移植后医疗资源利用更大。
研究设计与样本
- 回顾性研究,纳入2018至2019年北美10个中心接受肝移植的患者318例。
- 采用欧洲肝病学会-慢加急性肝衰竭(EASL-CLIF)标准判定ACLF。
主要发现
- 318例中无ACLF 106例(33.3%)、ACLF-1 61例(19.1%)、ACLF-2 74例(23.2%)、ACLF-3 77例(24.2%)。
- ACLF患者较无ACLF患者移植后住院时长、透析时长、出院至康复中心比例及30天再入院率均更高(P < .001、P < .001、P < .001、P = .042)。
- 多变量负二项回归显示,ACLF-1、ACLF-2、ACLF-3患者住院时长分别较无ACLF者延长1.9天(95%CI 0.82-7.51)、6.7天(95%CI 2.5-24.3)、19.3天(95%CI 1.2-39.7)。
- 移植时ACLF-3者透析时长较低级别ACLF延长9.7天(95%CI 4.6-48.8)。
- 多变量 logistic 回归显示,ACLF-1、ACLF-2、ACLF-3者出院至康复中心的OR分别为1.79(95%CI 1.09-4.54)、2.23(95%CI 1.12-5.01)、2.23(95%CI 1.40-5.73);移植后发生细菌感染预测住院时长(20.9天;95%CI 6.1-38.5)和30天再入院(OR 1.39;95%CI 1.17-2.25)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Although liver transplantation (LT) has been demonstrated to provide survival benefit for patients with acute-on-chronic liver failure (ACLF), data are lacking regarding resource utilization for this population after LT. METHODS: We retrospectively reviewed data from 10 centers in North America of patients transplanted between 2018 and 2019. ACLF was identified by using the European Association for the Study of the Liver-Chronic Liver Failure criteria. RESULTS: We studied 318 patients of whom 106 patients (33.3%) had no ACLF, 61 (19.1%) had ACLF-1, 74 (23.2%) had ACLF-2, and 77 (24.2%) had ACLF-3 at transplantation. Healthcare resource utilization after LT was greater among recipients with ACLF compared with patients without ACLF regarding median post-LT length of hospital stay (LOS) (P < .001), length of post-LT dialysis (P < .001), discharge to a rehabilitation center (P < .001), and 30-day readmission rates (P = .042). Multivariable negative binomial regression analysis demonstrated a significantly longer LOS for patients with ACLF-1 (1.9 days; 95% confidence interval [CI], 0.82-7.51), ACLF-2 (6.7 days; 95% CI, 2.5-24.3), and ACLF-3 (19.3 days; 95% CI, 1.2-39.7), compared with recipients without ACLF. Presence of ACLF-3 at LT was also associated with longer length of dialysis after LT (9.7 days; 95% CI, 4.6-48.8) relative to lower grades. Multivariable logistic regression analysis revealed greater likelihood of discharge to a rehabilitation center among recipients with ACLF-1 (odds ratio [OR], 1.79; 95% CI, 1.09-4.54), ACLF-2 (OR, 2.23; 95% CI, 1.12-5.01), and ACLF-3 (OR, 2.23; 95% CI, 1.40-5.73). Development of bacterial infection after LT also predicted LOS (20.9 days; 95% CI, 6.1-38.5) and 30-day readmissions (OR, 1.39; 95% CI, 1.17-2.25). CONCLUSIONS: Patients with ACLF at LT, particularly ACLF-3, have greater post-transplant healthcare resource utilization.
引用
- Sundaram V, Lindenmeyer CC, Shetty K, et al. Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation. Clin Gastroenterol Hepatol. 2022. PMID: 35337982. doi:10.1016/j.cgh.2022.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。